Evidence map›Paper›PMID 29298162›Full record

ArticleEnvironmental health perspectives2018

Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.

Kristen Lyall, Vincent M Yau, Robin Hansen, Martin Kharrazi, Cathleen K Yoshida, Antonia M Calafat, Gayle Windham, Lisa A Croen

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Kristen LyallA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, USA
Vincent M YauDivision of Research, Kaiser Permanente, Oakland, California, USA
Robin HansenMIND Institute and the Department of Pediatrics, University of California, Davis, Davis, California, USA
Martin KharraziDivision of Environmental and Occupational Disease Control, California Department of Public Health, Richmond, California, USA
Cathleen K YoshidaDivision of Research, Kaiser Permanente, Oakland, California, USA
Antonia M CalafatNational Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Gayle WindhamDivision of Environmental and Occupational Disease Control, California Department of Public Health, Richmond, California, USA
Lisa A CroenDivision of Research, Kaiser Permanente, Oakland, California, USA
Kaiser Permanente · USCalifornia Department of Public Health · USCenters for Disease Control and Prevention · USDrexel University · USUniversity of California, Davis · US

Funding

Prenatal and Neonatal Biologic Markers for AutismR01ES016669 · NIEHS · KAISER FOUNDATION RESEARCH INSTITUTE · PI CROEN, LISA A · 2010 to 2014
$3.5M
NIEHS NIH HHS R01 ES016669
6 · The paper itself

Abstract

backgroundEmerging work has examined neurodevelopmental outcomes following prenatal exposure to per- and polyfluoroalkyl substances (PFAS), but few studies have assessed associations with autism spectrum disorder (ASD).

objectivesOur objective was to estimate associations of maternal prenatal PFAS concentrations with ASD and intellectual disability (ID) in children.

methodsParticipants were from a population-based nested case-control study of children born from 2000 to 2003 in southern California, including children diagnosed with ASD (

resultsGeometric mean concentrations of most PFAS were lower in ASD and ID groups relative to GP controls. ASD was not significantly associated with prenatal concentrations of most PFAS, though significant inverse associations were found for perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) [adjusted ORs for the highest vs. lowest quartiles 0.62 (95% CI: 0.41, 0.93) and 0.64 (95% CI: 0.43, 0.97), respectively]. Results for ID were similar.

conclusionsResults from this large case-control study with prospectively collected prenatal measurements do not support the hypothesis that prenatal exposure to PFAS is positively associated with ASD or ID. https://doi.org/10.1289/EHP1830.

Indexed as

AdultAlkanesulfonic AcidsAutism Spectrum DisorderCaliforniaCaprylatesCase-Control StudiesChildChild, PreschoolEnvironmental PollutantsFemaleFluorocarbonsGestational AgeHumansIntellectual DisabilityLogistic ModelsMaleAlkanesulfonic AcidsCaprylatesEnvironmental PollutantsFluorocarbonsperfluorooctane sulfonic acidperfluorooctanoic acid

Identifiers

PMID29298162
PMCPMC6014693
OpenAlexW2782066897

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.